Epigral Ltd. Share Price

Overview

Epigral Ltd. share price is currently ₹892.51, down by - ₹12.54 (1.39%) from its previous closing price of ₹905.05. The share price has declined -18.68% over the past month and declined -45.81% over the past year. The stock's 52-week low and high are ₹794.34 and ₹1,703.95, respectively. Epigral Ltd. has a market capitalisation of ₹ 4,300.00 Cr. The share price was last updated on 23 Oct 2026, 03:29 PM IST.

Epigral Ltd.
Epigral Ltd.
EPIGRAL
 ₹0.00
- ₹12.54
1.39%
Chemicals
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:29:42 pm IST

Market Data

Open Price

 ₹912.58

Prev. Close

 ₹905.05
 ₹877.40

Day Low

 ₹912.58

Day High

 ₹794.34

52 Week Low

 ₹1,703.95

52 Week High

ChemicalsChemicals
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

14.21

Sector PE

28.52

PB Ratio

1.73

Sector PB

4.06

EPS

62.82

Dividend Yield

0.62

Today's Volume

42.660 K

5 Day Avg. Volume

39.857 K

PEG Ratio

-1.98

Market Cap.

₹ 4,300.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 50% at ₹5/Share
01-Jun-202601-Jun-2026
DividendsFinal Dividend of 35% at ₹3.5/Share
20-Jun-202521-Jun-2025
DividendsInterim Dividend of 25% at ₹2.5/Share
07-Feb-202507-Feb-2025

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
Bandhan Small Cap Fund - Regular Plan - Growth13.47 Lac
13.77 Lac
(2.23%)
HSBC Value Fund - Regular Plan - Growth4.95 Lac
4.95 Lac
no change
HSBC Multi Cap Fund - Regular Plan - Growth1.51 Lac
1.51 Lac
no change
Bandhan Business Cycle Fund - Regular Plan - Growth81.47 k
79.85 k
(1.99%)
Motilal Oswal BSE 1000 Index Fund - Regular Plan - Growth40
39
(2.5%)

About Epigral Ltd. 👋

Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Shrikant Pandey

Shrikant Pandey

27 Jul • 2:33 PM · SEBI-Registered Analyst

EPIGRAL

EPIGRAL Q1 : CONFIDENT ON GROWTH DESPITE GLOBAL HEADWINDS ; CHAIRMAN • 📈 Delivered 15% revenue growth with a healthy 25% EBITDA margin despite geopolitical volatility, raw material price swings and higher freight costs • 🏭 Approved ₹600 crore investment in Epoxy Resin & Formulations and a Multi-Purpose Plant (MPP) to drive future growth • 🔗 New projects will leverage internal raw materials, strengthening backward integration and improving manufacturing efficiency • 🌍 Epoxy Resin plant will cater to renewable energy, infrastructure, electronics, automotive and industrial sectors, while MPP will target pharma, agrochemical intermediates and water treatment chemicals • 🚀 Management remains optimistic on growth, backed by India's strong economic outlook and continued portfolio diversification

See More
Ankit Gupta

Ankit Gupta

2 May • 6:28 PM · SEBI-Registered Analyst

EPIGRAL
: Q4 CONS NET PROFIT 809M RUPEES VS 868M (YOY) || Q4 REVENUE 7.4B RUPEES VS 6.3B (YOY) Q4 EBITDA 1.68B RUPEES VS 1.74B (YOY) || Q4 EBITDA MARGIN 22.9% VS 27.6% (YOY)

See More
Tejaswi

Tejaswi

4 Mar • 12:34 PM · SEBI-Registered Analyst

Niche Inside The Chemical Maze

EPIGRAL
Epigral has quietly built a sharp niche in specialty and derivative chemicals, which is now at the heart of its mid‑cap growth story. The company started with basic chlor‑alkali products but has steadily shifted towards higher‑value derivatives such as CPVC resin, CPVC compounds, epichlorohydrin, chloromethanes and hydrogen peroxide, supplying over 15 downstream industries. This mix gives it exposure to durable themes like pipes and fittings, water treatment, construction, windmills, pharmaceuticals and agrochemicals, all of which need stable, specialty‑grade inputs. From a shareholder’s perspective, the value lies in backward‑integrated plants, very high margins for many of its niche products and a clear plan to move from basic chemicals to a 70:30 split in favour of derivatives and specialties. Epigral has also added an R&D centre and is expanding CPVC resin and CPVC‑compound capacity, which should enhance pricing power and utilisation over time. However, rapid capex for ECH and CPVC projects, commodity‑price swings and dependence on a few key segments mean profitability and cash conversion can be lumpy, posing a risk to near‑term earnings and valuations. In a market that rewards growth and quality but also punishes debt and over‑leveraged balance sheets, Epigral’s integrated model and strong return on capital can be beneficial for long‑term shareholders, provided execution remains clean and capacity is absorbed without long‑term under‑utilisation. For investors, the stock looks more attractive as a structural play with operational risk, rather than a safe, low‑volatility holding.

See More
Vibhu Jain

Vibhu Jain

6 Aug • 9:13 AM · SEBI-Registered Analyst

EPIGRAL

As of 5 August 2025, the technical trend for Epigral has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive trend, while the monthly MACD is mildly bearish, indicating some caution. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, reinforcing the upward momentum. However, daily moving averages are mildly bearish, suggesting short-term weakness. The KST is bullish on both weekly and monthly time frames, which adds to the overall bullish sentiment. The lack of signals from the RSI and the neutral stance from OBV indicate some indecision. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and KST indicators.

See More
Sanjay Ahuja

Sanjay Ahuja

2 Jul • 12:16 PM · SEBI-Registered Analyst

SPECIALITY CHEMICAL STOCKS WITH HIGH GROWTH TO KEEP A WATCH IN 2025

The specialty chemical sector in India is witnessing a massive growth. In fact some companies are significantly increasing their production capacities, thereby indicating a strong future growth potential. Initially, the chemical sector was more focussed on bulk chemicals, however with the China+1 strategy, the industry is now focussing on speciality chemicals. Every specialty chemical company is different, having a particular set of customers, unique research and development tactics, and it's dynamics. This is because specialty chemical manufacturers mostly focus on a specific category of chemicals, and there are a few who integrate multiple categories. Below are some specialty chemical companies that have grown significantly in the past three years and are looking forward to a strong sales growth:

PLATIND
- leading manufacturer of PVC stabilizers, lubricants, and CPVC additives
EPIGRAL
- largest producer of CPVC Resin, 5th largest manufacturer of Chloromethanes (CMS), and 3rd largest producer of Hydrogen Peroxide in India NAVIN FLUORINE - produces Anhydrous Hydrofluoric Acid (AHF), Diluted Hydrofluoric Acid (HF), refrigerants, and other complex chemicals
NEOGEN
- specializes in producing Bromine and lithium-based specialty chemicals JYOTI RESINS - manufactring wide range of wood adhesives / white glue

See More
Vimal K

Vimal K

5 May • 9:01 AM · SEBI-Registered Analyst

WATCH OUT FOR Q4 RESULTS TODAY.

Watch out for the stocks that will announce their results for the quarter ended on March 31, 2025 later today the 05-May-2025 : - Mahindra & Mahindra, Indian Hotels Company, Coforge, Computer Age Management Services, DCM Shriram, Onesource Specialty Pharma, Capri Global Capital, Jammu Kashmir Bank, CCL Products India, Epigral India, Ethos, Magellanic Cloud, Cigniti Technologies, Jash Engineering, Kalyani Steels and Prataap Snacks are among the companies that will announce their results for the March 2025 quarter today.

M&M
INDHOTEL
COFORGE
CAMS
DCMSHRIRAM
CGCL

See More

News & Events

Frequently Asked Questions

What is the share price of Epigral Ltd.?

What is the market cap of Epigral Ltd.?

Should I buy Epigral Ltd. stock now?

What is the 52 week high and low of Epigral Ltd.?

Is the Epigral Ltd. stock good to buy?

Is Epigral Ltd. a good buy for the long term?

Is Epigral Ltd. overvalued or undervalued?

What is the PE and PB ratio of Epigral Ltd.?

Start Now